Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates
- 20 October 2014
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 78 (5) , 1090-1101
Abstract
Aim: This study aims to investigate the clinical and demographic factors influencing gentamicin pharmacokinetics in a large cohort of unselected premature and term newborns and to evaluate optimal regimens in this population.Methods: All gentamicin concentration data, along with clinical and demographic characteristics, were retrieved from medical charts in a Neonatal Intensive Care Unit over 5 years within the frame of a routine therapeutic drug monitoring programme. Data were described using non‐linear mixed‐effects regression analysis ( nonmem®).Results: A total of 3039 gentamicin concentrations collected in 994 preterm and 455 term newborns were included in the analysis. A two compartment model best characterized gentamicin disposition. The average parameter estimates, for a median body weight of 2170 g, were clearance (CL) 0.089 l h−1 (CV 28%), central volume of distribution (Vc) 0.908 l (CV 18%), intercompartmental clearance (Q) 0.157 l h−1 and peripheral volume of distribution (Vp) 0.560 l. Body weight, gestational age and post‐natal age positively influenced CL. Dopamine co‐administration had a significant negative effect on CL, whereas the influence of indomethacin and furosemide was not significant. Both body weight and gestational age significantly influenced Vc. Model‐based simulations confirmed that, compared with term neonates, preterm infants need higher doses, superior to 4 mg kg−1, at extended intervals to achieve adequate concentrations.Conclusions: This observational study conducted in a large cohort of newborns confirms the importance of body weight and gestational age for dosage adjustment. The model will serve to set up dosing recommendations and elaborate a Bayesian tool for dosage individualization based on concentration monitoring.Keywords
This publication has 70 references indexed in Scilit:
- The Relationship between Drug Clearance and Body SizeClinical Pharmacokinetics, 2012
- Maturation of the Glomerular Filtration Rate in Neonates, as Reflected by Amikacin ClearanceClinical Pharmacokinetics, 2012
- Pharmacokinetic-Pharmacodynamic Model for Gentamicin and Its Adaptive Resistance with Predictions of Dosing Schedules in Newborn InfantsAntimicrobial Agents and Chemotherapy, 2012
- Pharmacological Considerations for the Proper Clinical Use of AminoglycosidesDrugs, 2011
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects ModelsThe AAPS Journal, 2011
- Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearanceBritish Journal of Clinical Pharmacology, 2006
- Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonatesJournal of Antimicrobial Chemotherapy, 2004
- A Size Standard for PharmacokineticsClinical Pharmacokinetics, 1996
- Principles of Drug Biodisposition in the NeonateClinical Pharmacokinetics, 1988
- Principles of Drug Biodisposition in the NeonateClinical Pharmacokinetics, 1988